Testosterone VTE Risk; Novel Clot Buster Flops Again; Saturated Fat Culpability
medpagetoday.com
The venous thromboembolism (VTE) risk warned about with testosterone treatment appears to be transient, peaking within 6 months after starting and then gradually declining.